Comparisons between available experimental data (mixing ratios) and calculated limits lead to the conclusion that the present numerical method may allow the screening of other fuel/oxidant systems potentially of interest for spacecraft propulsion as well as for the determination of the range of mixing ratios able to ensure auto-ignitibility (hypergolicity) in combustion devices.
Recognition of perinatal risks predisposing to the subsequent development of OSA may allow anticipatory screening to prevent the development of adverse consequences.
In addition, long-term spheroid-forming assay may allow rapid screening of tumors for enrichment in cancer stem cells, identification of additional stem cell markers, and development of potentially curative therapies that target the putative cancer stem cell.
Fortunately, with the advent and increased usage of nucleic acid amplification techniques and fluorescent in situ hybridisation, such alternate techniques are more readily available; moreover, coincidental use of microarray technologies with nucleic acid amplifications may allow for screening of thousands of genes (Farkas et al, 1996).
More recent experiments have also proven zebrafish a useful organism for drug screens using whole vertebrates, suggesting that identification of dystrophic zebrafish mutants may allow drug screens for muscular dystrophy therapeutics.
We may then have a test to allow screening for selecting patients prior to performing more complex tests or to decide whether to intensify the interventions in lifestyle or with drugs (statins, acetylsalicillic acid, etc).
The worry, then, is that the criteria may allow us to screen in certain 'fish stories' about truth.
Knowledge of epigenetic information across iPS cells derived from different cell types can be used as a signature for "stemness" and may allow us to screen for optimum iPS/ES cells and to validate and monitor iPS/ES cell derivatives for human therapeutic applications.
In addition, knowledge of the DNA methylation profile in human ES and iPS cells derived from different cell types is absolutely imperative and may allow us to screen for optimum iPS/ES cells and to validate and monitor iPS/ES cell derivatives for human therapeutic applications.
This result indicates that the method may allow for efficient screening of cells for the presence of other circular DNA species, including genomes of intracellular pathogens.
